Charles B. Duke - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Molecular Cancer Therapeutics|September 11, 2010

I-387, a novel antimitotic indole, displays a potent in vitro and in vivo antitumor activity with less neurotoxicitySunjoo Ahn, Charles B Duke, Christina M Barrett, et al.

Wilderness & Environmental Medicine|March 25, 2020

Hypertension and Acute Mountain Sickness in Himalayan Trekkers in Nepal: An Observational Cohort StudyCharles B Duke, T Douglas Sallade, Jennifer Starling, et al.

Cancer Research|October 6, 2017

Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate CancerSuriyan Ponnusamy, Christopher C Coss, Thirumagal Thiyagarajan, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Molecular Cancer Therapeutics|September 11, 2010

I-387, a novel antimitotic indole, displays a potent in vitro and in vivo antitumor activity with less neurotoxicitySunjoo Ahn, Charles B Duke, Christina M Barrett, et al.

Wilderness & Environmental Medicine|March 25, 2020

Hypertension and Acute Mountain Sickness in Himalayan Trekkers in Nepal: An Observational Cohort StudyCharles B Duke, T Douglas Sallade, Jennifer Starling, et al.

Cancer Research|October 6, 2017

Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate CancerSuriyan Ponnusamy, Christopher C Coss, Thirumagal Thiyagarajan, et al.

Pageof 2